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Despite studies based on deletion or activation of
intracellular components of the canonical Wingless
related (Wnt) pathway, the role of Wnts in hemato-
lymphopoiesis remains controversial. Using gain-
of-function and loss-of-function models, we found
that Wnt4 differentially affected diverse subsets of
hematopoietic stem and progenitor cells. Bone-mar-
row and thymic Lin–Sca1+Kithi cells (LSKs) were the
key targets of Wnt4. In adult mice, Wnt4-induced
expansion of Flt3+ bone-marrow LSKs (lymphoid-
primed multipotent progenitors) led to a sizeable
accumulation of the most immature thymocyte sub-
sets (upstream of b-selection) and a major increase
in thymopoiesis. Conversely, Wnt4–/– neonates
showed low frequencies of bone-marrow LSKs and
thymic hypocellularity. We provide compelling evi-
dence that Wnt4 activates noncanonical (b-catenin-
independent) signaling and that its effects on hema-
topoietic cells are mainly non-cell-autonomous. Our
work shows that Wnt4 overexpression has a unique
ability to expand Flt3+ LSKs in adults and demon-
strates that noncanonical Wnt signaling regulates
thymopoiesis.
INTRODUCTION
Wnts are highly conserved secreted proteins that play a crucial
role in organismal patterning throughout the animal kingdom
(Clevers, 2006). Mammals have 19 Wnt genes that, through phy-
logenetic analysis, can be placed in 12 subfamilies (Prud’homme
et al., 2002). The emergence of the Wnt subfamilies occurred very
early in metazoan evolution. The reason for the early expansion of
the Wnt family and its maintenance along multiple disparate line-
ages over 650 million years remains an enigma (Gordon and
Nusse, 2006). A substantial body of evidence implicates Wnt sig-
naling in the postembryonic regulation of mammalian stem cell
number and differentiation (Reya and Clevers, 2005). Neverthe-less, despite remarkable efforts, the role of Wnt signaling in hema-
topoiesis and lymphopoiesis remains a most contentious issue.
There is incontrovertible evidence that ablation or induction of
several components of the Wnt pathway can affect the behavior
of hematolymphoid progenitors (Gounari et al., 2001; Kirstetter
et al., 2006; Scheller et al., 2006; Zhao et al., 2007). However,
the biological relevance of these observations and the precise
role of specific Wnt proteins are debatable. Practically all studies
on the role of Wnt signaling in hematolymphopoiesis have fo-
cused on intracellular components of the canonical Wnt pathway
such as b-catenin and Tcf-1, rather than on Wnt proteins and
their cell-surface receptors. That approach provides a biased
perspective on the role of Wnt signaling, mainly for two reasons.
First, intracellular components of the Wnt pathway (e.g., Dishev-
elled-1, glycogen synthase kinase 3b, and b-catenin) interact
with other signaling pathways including bone morphogenetic
protein (BMP), extracellular signal-regulated kinase (ERK),
GTPase cell-division cycle 42 (CDC42) and transforming growth
factor b (TGFb). Second, Wnt signaling can also occur through
several b-catenin-independent pathways. These signals are me-
diated by factors as diverse as calcium and calmodulin-depen-
dent kinase II and protein kinase C; TGFb-activated kinase and
Nemo-like kinase; and lastly the small GTP-binding proteins
RhoA and Rac, as well as the Jun-N-terminal kinase (Altschul
et al., 1990; Veeman et al., 2003; Seifert and Mlodzik, 2007).
Furthermore, Wnt proteins are not intrinsically canonical or non-
canonical, and Wnt signaling output ultimately depends on the
receptor context. Thus, Wnt5a can activate or inhibit the canon-
ical b-catenin pathway after binding to Frizzled 4 and Ror2
receptors, respectively (Mikels and Nusse, 2006). Compounding
the complexity of Wnt-induced responses, studies based on
deletion or stabilization of b-catenin have yielded discrepancies
(Gounari et al., 2001; Koch et al., 2008).
Our goal was to evaluate the role of one specific Wnt protein,
Wnt4, on hematopoiesis and lymphopoiesis. We were particu-
larly interested in T cell development because all aging mammals
develop thymic involution that is due at least in part to quantita-
tive and qualitative defects in hematolymphoid progenitors
(Linton and Dorshkind, 2004). We focused on Wnt4 for several
reasons. Wnt4 is one of the most abundant Wnts in the
thymus, where it is produced by thymocytes and stromal cellsImmunity 29, 57–67, July 18, 2008 ª2008 Elsevier Inc. 57
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Wnt4 Enhances Thymopoiesis(Balciunaite et al., 2002). Study of Wnt4/ mice (that die of renal
failure shortly after birth) suggests that Wnt4 may have a nonre-
dundant role in fetal thymopoiesis (Mulroy et al., 2002). Further-
more, we found that lymph-node-resident hematolymphoid
progenitors are able to generate mature T cells when they are
cultured in the presence but not in the absence of Wnt4 (Terra
et al., 2005). Using Wnt4–/– neonates, we found that Wnt4
was necessary to maintain the pool size of bone-marrow
Lin–Sca1+Kithi cells (LSKs) and a normal thymic cellularity. In
adult mice, the key consequence of Wnt4 overexpression was
to expand nonrenewing lymphoid-primed multipotent progeni-
tors (LMPPs; Flt3+ LSKs) downstream of hematopoietic stem
cells (HSCs; Flt3– LSKs). Expansion of LMPPs was associated
with a commensurate accumulation of intrathymic LSKs and
a major increase in thymic cellularity. Notably, we show that Wnt4
induced noncanonical Wnt signaling in hematopoietic cells.
RESULTS
Wnt4 Increases Thymic Cellularity
To assess the effect of Wnt4 on hematolymphoid cells, we recon-
stituted irradiated recipient mice with fetal liver (FL) cells trans-
duced with retroviral vectors encoding Wnt4-GFP or GFP
(Figure S1 available online) as previously described (Chagraoui
et al., 2006). We evaluated multilineage repopulation by long-
term HSCs by analysis of thymus, mesenteric lymph nodes
(LNs), spleen, and bone marrow (BM) of primary recipients
16 weeks after injection. Wnt4 protein expression in reconsti-
tuted chimeras was confirmed by immunoblotting (Figure S2).
Wnt4 overexpression did not affect the cellularity of secondary
lymphoid organs or the BM but induced a major (3.3-fold) in-
crease in thymic cellularity (Figure 1A). In recipients of FL cells
overexpressing Wnt4 (Wnt4+), the proportions of double-nega-
tive (DN), double-positive, and single-positive thymocyte sub-
sets were normal (Figure 1C). Accordingly, absolute cell numbers
of all these cell subsets were increased relative to controls
(Figure 1C). However, further analysis revealed that in the DN
compartment, the proportion of early thymocyte progenitors
(ETP; Linlo/CD117hiCD25–) and DN2 (Linlo/CD117hiCD25+)
cells was increased by 3- to 3.5-fold in recipients of Wnt4+ FL
cells relative to controls (Figure 1D). Thus, the absolute numbers
of ETPs and DN2 cells in the thymus was increased by 9- to
10-fold. Downstream of ETPs and DN2 thymocytes, the propor-
tion of DN3 thymocytes was similar in recipients of Wnt4+ and
control FL cells (Figure 1D). Thus, overexpression of Wnt4 in do-
nor FL cells led to a selective increase in thymic cellularity of pri-
mary recipients with a disproportionate accumulation of the most
immature thymocyte subsets, ETPs and DN2 cells. The major in-
crease in thymic cellularity of Wnt4+ relative to control recipients
was not due to selective expansion of transduced (GFP+) relative
to nontransduced cells. Indeed, the proportion of GFP+ cells was
similar in both groups and was below 20% at week 16 (Figure 1B).
We conclude that, in agreement with the fact that it is a secreted
protein, Wnt4 had paracrine effects on nontransduced cells.
Overexpression of Wnt4 Induces an Accumulation
of BM LSKs and Common Lymphoid Progenitors
Evidence suggests that two types of BM Lin– cells may seed the thy-
mus and thereby sustain thymopoiesis: LSKs and the more differen-58 Immunity 29, 57–67, July 18, 2008 ª2008 Elsevier Inc.tiatedcommon lymphoidprogenitors (CLPs) (Lin–Sca1+KitloCD127+)
(Bhandoola et al., 2007). We therefore wondered whether expansion
of these progenitor subsets in the BM could be responsible for the
accumulation of ETPs and DN2 cells in the thymus of mice reconsti-
tuted with Wnt4+ FL cells. We found that the numbers of LSKs and
CLPs were increased 2.8- and 2.3-fold, respectively, in the BM
of mice transplanted with Wnt4+ FL cells (Figure 2A). Thus, although
overexpression of Wnt4 did not affect global BM cellularity
(Figure 1A), it induced a conspicuous increase in small BM cell
subsets (LSKs and CLPs).
Wnt4 Has a Threshold Effect on Discrete
Stages of B Lymphopoiesis
Because LSKs and CLPs also give rise to B lineage cells, we next
asked whether the accumulation of CLPs induced by Wnt4 would
translate into enhanced B lymphopoiesis. The various stages of
B lymphocyte differentiation were identified with surface markers
B220, CD43, CD24, IgM, and IgD as previously described (Hardy
and Hayakawa, 2001) and depicted in Figure 2B. The mean per-
centage and absolute number of B220+ cells were not greater in
recipients of Wnt4+ FL cells than in controls (Figure 2C). Thus,
Wnt4 overexpression did not have a major overall impact on
the size of the B lineage compartment. To determine whether
Wnt4 might have a more subtle or threshold effect on B cell de-
velopment, we concentrated on the mice with the strongest
Wnt4 expression on the basis of the percentage of GFP+ BM
cells. Wnt4hi mice had a larger proportion of their B220+ cells in
pre-B II and immature B fractions (Hardy fractions D and E, re-
spectively) than control chimeras (Figures 2B and 2D) or mice ex-
pressing low amounts of exogenous Wnt4 (Figure 2B and data
not shown). However, Wnt4hi mice did not show substantial
changes in subcompartments upstream or downstream of frac-
tions D and E. We conclude that on discrete stages of B lympho-
poiesis, Wnt4 has a threshold effect that does not impinge on the
size of the mature B cell compartment in the BM (Figures 2B–2D)
or in secondary lymphoid organs (Figure S3).
The Effect of Wnt4 Is Not Lymphoid Restricted
Because LSKs can generate all hematopoietic lineages, we next
sought to determine whether Wnt4-induced expansion of BM
LSKs influenced nonlymphoid cell lineages. Myeloid progenitor
cells are found within the LinCD127Sca1CD117(Kit)+ fraction
of the BM and can be further differentiated on the basis of
their expression of CD34 and CD16CD32 (Akashi et al., 2000;
Sitnicka et al., 2002). Recipients of Wnt4+ FL cells had more
LinCD127Sca1CD117+ cells and in particular, more
CD34+CD16CD32hi granulocyte-monocyte progenitors than
control mice (GMPs; Figure 3A). This translated into an increase
in both CD11b+Gr-1–/lo monocytic and CD11b+Gr-1hi granulo-
cytic fractions (Figure 3B). Interestingly, although the size of
the megakaryocyte-erythrocyte progenitor (MEP) population
was not affected (Figure 3A), we found a significant decrease
in the immature CD71+ erythroblasts (fractions I–III; Figure 3C),
indicating that erythroid development was impaired by overex-
pression of Wnt4. Moreover, the percentage of Wnt4-expressing
cells (GFP+) within the erythroid lineage was significantly de-
creased as compared to that within the total BM population
(data not shown), suggesting that autocrine Wnt4 specifically
interfered with erythropoiesis.
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Wnt4 Enhances ThymopoiesisIt is important to note that the hematopoietic overexpression
of Wnt4 had little impact on mature cells in secondary lymphoid
organs (Figure S3) and peripheral blood (data not shown). Over-
all, Wnt4 exerted its effects in the primary hematopoietic organ
(BM) and the primary T lymphoid organ (thymus), where it in-
creased the size of discrete populations of myeloid and lymphoid
progenitors. By far, the most dramatic effect of Wnt4 was to
increase thymopoiesis.
Wnt4 Decreases the Proportion of Cycling LSKs
and Is a Survival Factor for Flt3+ LSKs
The LSK compartment contains three hierarchically related
subpopulations: CD34–Flt3– cells enriched for long-term recon-
stituting HSCs, CD34+Flt3– cells that are collectively defined as
short-term reconstituting HSCs, and Flt3+ lymphoid-primed mul-
Figure 1. Thymic Cellularity Is Increased in
Recipients of Wt4-Transduced FL Cells
(A) Cell numbers in the BM (two tibiae and femurs), spleen,
mesenteric LN, and thymus were assessed 16 weeks after
injection of FL cells transduced with Wnt4-GFP or GFP.
(B) Proportion of GFP+ cells among FL cells injected on
day 0 and recipient cells harvested after 16 weeks.
(C) DN, double-positive (DP), and mature thymocyte
subsets were analyzed with CD4 and CD8 staining.
(D) Proportion of ETP (Linlo/negCD117hiCD25–), DN2
cells (Linlo/negCD117hiCD25+), and DN3 cells (Linlo/neg
CD117CD25+) in thymi of recipients of Wnt4+ or control
FL cells. Dot plots of thymocytes stained with antibodies
against CD117 and CD25 and gated on Linlo/neg as de-
scribed by Bhandoola and Sambandam (2006) are shown.
Histograms depict the mean ± SEM for the two
experimental groups. n = 8 and n = 6 mice per group for
Wnt4+ and control chimeras, respectively. ***p < 0.01,
yp < 0.005.
tipotent progenitors (LMPPs) (Ma˚nsson et al.,
2007). Progression from CD34–Flt3– HSCs to
Flt3+ LMPPs is accompanied by gradual down-
regulation of megakaryocyte-erythrocyte-asso-
ciated transcripts, sustained granulocyte-mac-
rophage priming, and a distinct upregulation of
common lymphoid genes (Ma˚nsson et al.,
2007). The fact that Wnt4 induced a relative ex-
pansion of myeloid and lymphoid lineages over
erythroid cells (Figures 1–3) suggests that Wnt4
preferentially influenced the Flt3+ fraction of
LSKs (LMPPs) (Ma˚nsson et al., 2007). To test
this hypothesis, we performed Flt3 staining on
BM LSKs. We found that the proportion of
LSKs expressing Flt3 was 26% in recipients of
Wnt4+ FL cells relative to 13% in controls
(Figure 4A). Accordingly, whereas the number
of Flt3– LSKs was increased 1.9-fold, that of
Flt3+ LSKs was increased 3.3-fold in recipients
of Wnt4+ FL cells relative to controls (Figure 4A).
Wnts have been reported to regulate prolifer-
ation and survival of the responding cells (Willert
et al., 2003). To decipher how Wnt4 augmented
the size of the LSK compartment, we therefore
analyzed the cell-cycle status and apoptotic rate of BM Flt3+
and Flt3– LSKs. We observed, as others have (Yang et al.,
2005), that the proportion of cycling cells (S+G2/M) was greater
in Flt3+ than Flt3– LSKs (Figure 4B). Nonetheless, the salient find-
ing was that Wnt4 decreased the proportion of cycling cells
(S+G2/M) among both Flt3
+ and Flt3– LSKs (Figure 4B). Further-
more, the proportion of apoptotic (Annexin-V+) Flt3+ LSKs was
lower in recipients of Wnt4+ FL cells (4.5%) than in controls
(19%) (Figure 4C). By contrast, no difference was seen in the
relatively low apoptotic rate of Flt3– LSK populations
(Figure 4C). Thus, in both Flt3+ and Flt3– subsets, the proportion
of cycling cells was decreased by Wnt4. In addition, Wnt4
specifically enhanced the survival of Flt3+ LSKs. We expand in
the Discussion on the concept that the increased proportion of
G0/G1 cell-cycle-arrested cells and the enhancement of survivalImmunity 29, 57–67, July 18, 2008 ª2008 Elsevier Inc. 59
Immunity
Wnt4 Enhances Thymopoiesisof Flt3+ LSKs are probably linked and that together they explain
well the expansion of Flt3+ LSKs induced by Wnt4.
The Flt3– LSK compartment contains short-term and long-
term HSCs. To address whether the increased frequency of
Flt3– LSKs in the BM of Wnt4+ primary recipients (Figure 4A)
translated into an increased frequency of genuine long-term
HSCs, we transplanted Ly5.2+ BM cells from primary recipients
under limiting dilution conditions into irradiated secondary recip-
ients in conjunction with 23 105 helper cells (both recipients and
helper cells were Ly5.1+; Figure S1) (Thorsteinsdottir et al., 2002).
The contribution of Ly5.2+ cells to lymphoid and myeloid recon-
stitution was then assessed by flow cytometry in the peripheral
blood of secondary recipients 16 weeks after transplant. The
frequency of HSCs was determined with Poisson probabilities
and revealed a modest increase in the BM of Wnt4+ primary
recipients (1/72,000 cells) when compared to control primary
recipients (1/200,000) (Figure 4E). Although the 3-fold increase
in HSC frequency did not reach statistical significance (see
Figure 2. Wnt4 Overexpression Increases
the Frequencies of LSKs and CLPs and
Affects Discrete Stages of B Lymphopoiesis
(A) BM cells (two tibiae and femurs) from recipients
of Wnt4+ (n = 3) and control (n = 4) FL cells were
stained for Lin markers, CD117, Sca1, and
CD127. One representative dot plot is shown
(left) from four independent experiments perfor-
med. Histograms show percentage and absolute
numbers of LSKs and CLPs (mean ± SEM).
(B–D) BM cells from Wnt4lo (<10% GFP+ cells; top
panels of [B]) and Wnt4hi (>10% GFP+ cells; mid-
dle panels of [B]) and control primary recipients
(bottom panels of [B]) were stained with antibodies
against B220, CD43, CD24, IgM, and IgD.
(B) Representative flow-cytometry dot plots.
(C) Proportion and absolute number of B220+ cells
in Wnt4+ and control mice.
(D) Proportion and absolute numbers of B cell de-
velopmental subsets in Wnt4hi and control mice.
Bar graphs represent the mean ± SEM from five
separate experiments. n = 14 for Wnt4+ (7 Wnt4hi +
7 Wnt4lo) and n = 8 for control chimeras.
*p < 0.05, **p < 0.03, ***p < 0.01, yp < 0.005, and
yyp < 0.0005.
overlapping confidence intervals), it
dovetailed well with the commensurate
increase in numbers of Flt3– LSKs
(Figure 4A).
Thymic Cellularity Correlates
with Numbers of Flt3+ BM LSKs
Wnt4 overexpression expanded BM
LSKs and CLPs (Figure 2A) and increased
thymic cellularity (Figure 1A). When we
pooled together recipients of Wnt4+ and
control FL cells, thymic cellularity in indi-
vidual mice varied across a 10-fold range
(Figure 4D). We found that thymic cellu-
larity strongly correlated with the fre-
quency of BM Flt3+ LSKs but not that of
BM Flt3– LSKs (Figure 4D) or of CLPs (R = 0.25; data not shown).
These data suggest that expansion of BM Flt3+ LSKs was re-
sponsible for enhancement of thymopoiesis by Wnt4. Further-
more, they are consistent with compelling evidence that in nor-
mal physiology, ETPs arise from Flt3+ LSKs (or closely related
multipotent BM progenitors) and not from HSCs or CLPs
(Schwarz et al., 2007; Bell and Bhandoola, 2008; Wada et al.,
2008).
In adult mice reconstituted with fetal liver cells overexpressing
Wnt4, thymic hypercellularity was associated with an increase in
the number and proportion of thymic LSKs (ETPs) (Figures 1 and 4).
Downstream of DN2 cells, the proportion of thymocyte subsets
was similar in recipients of fetal liver cells overexpressing Wnt4
or not. This suggests that Wnt4 enhances thymopoiesis by
expanding the pool of ETPs but does not directly influence
later stages of thymopoiesis. To further substantiate that as-
sumption, we assessed the T progenitor potential of BM LSKs
and thymic ETPs from reconstituted mice cultured in vitro on60 Immunity 29, 57–67, July 18, 2008 ª2008 Elsevier Inc.
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Wnt4 Enhances ThymopoiesisOP9-DL1 stromal cells (Terra et al., 2005). FACS-sorted LSKs
and ETPs were obtained from primary recipients 16 weeks after
injection of FL cells transduced with Wnt4-GFP or GFP, and
equal numbers (n = 500 cells/mouse) were seeded on OP9-
DL1 stromal cells. We found no differences between the two
groups in terms of in vitro expansion or kinetics of differentiation
(Figure S4). We conclude that Wnt4 enhances thymopoiesis by
increasing the number of thymic ETPs and not by increasing
the number of T cells produced per ETP.
Transcriptional Targets of Wnt4 in BM LSKs
To identify transcripts that were regulated by Wnt4, we per-
formed quantitative real-time RT-PCR on GFP-negative BM
LSKs sorted from Wnt4+ or control chimeras. We focused on
GFP-negative (nontransduced) LSKs because they were more
abundant than GFP+ LSKs and the effects of Wnt4 in our model
were predominantly if not exclusively paracrine (non-cell auton-
omous) (Figure 1B). We have shown that Wnt4 increased the pro-
portion of cell-cycle-arrested cells among Flt3– and Flt3+ LSKs
and enhanced the survival of Flt3+ LSKs (Figures 4A–4C). We
therefore tested 62 genes that are related to the Wnt pathway
and/or that regulate cell cycling, maintenance, survival, or early
myeloid and lymphoid differentiation of LSKs (Table S1). Flow-
cytometry analysis of cell samples used in RT-PCR analyses
showed that the proportion of Flt3+ LSKs was greater in Wnt4+
Figure 3. Wnt4 Enhances Myeloid but
DecreasesErythroidDevelopment in theBM
(A–C) Flow-cytometry analyses of BM cells from
primary recipients of Wnt4+ and control FL cells.
(A) Subsets of myeloid progenitors (Lin–CD127–
CD117hiSca-1– cells): common myeloid progeni-
tors (CMP: CD34+CD16CD32lo), granulocyte-
monocyte progenitors (GMP; CD34+CD16
CD32hi), and megaryocyte-erythrocyte progeni-
tors (MEP; CD34–CD16CD32lo).
(B) CD11b+Gr-1–/lo monocytes and CD11b+Gr-1hi
granulocytes.
(C) Immature erythroid fractions based on staining
for CD71 and Ter119. Histograms depict the mean
± SEM from four separate experiments. n = 7 for
Wnt4+ and n = 4 for control chimeras.*p < 0.05,
**p < 0.03, ***p < 0.01, and yp < 0.005.
than control recipients, as previously
shown in Figure 4A. However, we de-
tected no upregulation of Flt3 transcripts
in Wnt4+ LSKs (data not shown). One
possibility is that modulation of Flt3 pro-
tein by Wnt4 occurred at the posttran-
scriptional level. Overall, 24 out of 62
genes were differentially expressed in
LSKs harvested from recipients of
Wnt4+ versus control FL cells (Figure 5).
When compared with LSKs from con-
trols, LSKs from Wnt4+ mice exhibited
four major attributes. First, they displayed
an upregulation of nine genes supporting
cell maintenance (Figure 5): Ccnd2,
Cxcr4, Foxo1, Foxo4, Hoxa9, Hoxa10, Hoxb4, Meis1, and Pten.
Of note, upregulation of Hoxa10 is a plausible explanation for
the impairment of erythroid development by Wnt4 (Figure 3C)
(Magnusson et al., 2007). Second, they showed an induction of
five cell-cycle inhibitors (Figure 5): Cdkn1b, Cdkn1c, Cdkn2d,
Mxd1, and Rbl2. Induction of Foxo1 and Foxo4 genes may be
responsible for the observed upregulation of Cdkn1b and Rbl2
(Nakae et al., 2003). The third feature was an upregulation of
the antiapoptotic gene Bcl2l1 (Figure 5); a nearly significant
2.4-fold upregulation of Bcl2 was also observed (p = 0.06, data
not shown). The fourth key finding was that out of the four classic
transcriptional targets of the canonical Wnt pathway tested
(Ccnd1, Fos, Jun, and Myc), none were significantly upregulated
by Wnt4 in LSKs (Figure 6A).
Wnt4-dependent upregulation of several additional genes in
LSKs raises other attractive but more speculative possibilities
(Figure 5). Upregulation of three components of the Wnt pathway
(Fzd4, Fzd6, and Tcf4) suggests that Wnt4 signals may regulate
signaling by other Wnts, whereas induction ofHes1 andDll1 sug-
gests that Wnt4 may amplify Notch signaling in LSKs. Increased
levels ofKit, Flt3l, and Il2ramight support cell expansion from the
LSK to the DN2 thymocyte development stage, whereas induc-
tion of Cxcr4 and Selp may support interactions between LSKs
and the thymic microenvironment (Rossi et al., 2005b; Dar
et al., 2005).Immunity 29, 57–67, July 18, 2008 ª2008 Elsevier Inc. 61
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Wnt4 Enhances ThymopoiesisFigure 4. Analysis of BM LSK Subsets
(A) BM LSKs from recipient mice were analyzed for Flt3 expression by flow cytometry. One representative dot plot is shown for Wnt4+ (top) and control chimeras
(bottom). Histograms show percentage and numbers of total LSKs, Flt3+ LSKs, and Flt3– LSKs. Numbers in parentheses indicate the average fold increase in
Wnt4+ versus control recipients. The farthest-right graph indicates the percentage of Flt3+ cells within the LSK compartment.
(B) Cell-cycle analysis was performed on BM Flt3+ and Flt3– LSKs. We show representative profiles (top) and average percentages of LSKs in G0/G1 and S+G2/M
phase of the cell cycle (bottom).
(C) Annexin-V staining was analyzed after gating on cells negative for propidium iodide (to exclude necrotic cells). Bar graphs depict percentage and numbers of
Annexin-V+ cells in Flt3+ and Flt3– LSKs. Data in (A)–(C) represent the mean ± SEM of 3 mice per group. *p < 0.05 and **p < 0.03.
(D) Correlation between thymic cellularity and numbers of BM Flt3+ or Flt3– LSKs. The Pearson linear correlation coefficient is represented by R values.
(E) Limiting-dilution assay was performed with Ly5.2+ BM cells from primary Wnt4+ and control recipients coinjected with Ly5.1+ helper BM cells in irradiated
Ly5.1+ secondary recipients (n = 25 recipients/group). Mice were considered reconstituted if more than 0.5% of myeloid (anti-Gr-1 /Mac-1), B (anti-CD19),
and T (anti-TCRb) lineage cells were Ly5.2+. Frequency of long-term HSCs (competitive reconstituting units) was determined with Poisson probabilities; 95%
confidence intervals were 2.9 3 104 to 1.8 3 105 for Wnt4+ recipients and 7 3 104 to 5.8 3 105 for controls.62 Immunity 29, 57–67, July 18, 2008 ª2008 Elsevier Inc.
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of LSKs and Thymic Hypocellularity
To complement our experiments based on a gain-of-function
model and acquire further insights into the physiological role of
Wnt4, we studied Wnt4–/– mice. Because Wnt4–/– mice die
shortly after birth (Stark et al., 1994), we were able to study neo-
nates (at 8–12 hr after birth) but not adult Wnt4–/– mice. We first
Figure 5. Transcriptional Targets of Wnt4 in
LSKs
Real-time RT-PCR analyses were performed on
sorted GFP-negative BM LSKs from recipients of
Wnt4+ or control FL cells. A total of 62 genes
were analyzed (Table S1). Shown are the gene
transcripts that were differentially expressed in
the two groups. Transcript levels normalized to
Gapdh are expressed as mean ± SEM (n = 3) rela-
tive to control LSKs (dotted line). Data represent
the mean ± SEM from three independent ex-
periments.*p < 0.05, **p < 0.03, ***p < 0.01, and
yp < 0.005.
Figure 6. Wnt4 Activates JNK but Not The Canonical Wnt Pathway
(A) Real-time RT-PCR analysis of four classic target genes of the canonical Wnt pathway was performed on GFP-negative BM LSKs from as described in Figure 5.
None of the genes were differentially expressed in mice reconstituted with Wnt4+ versus control FL cells.
(B) Representative immunoblots from FL cells cocultured for 15 min, 60 min, or 120 min with Wnt4-producing versus control fibroblasts, showing b-catenin, phos-
phorylated JNK2 (T183/Y185), and total JNK2. Beta-actin was used as a loading control. Graphs represent relative intensities of b-catenin and phosphorylated
JNK2 (mean ± SEM) from three separate experiments. *p < 0.05 and yyp < 0.0005.
verified that, in contrast to Wnt4+/– and
Wnt4+/+ littermates, no Wnt4 transcripts
are found in the thymus and bone marrow
of Wnt4–/– mice (Figure 7A). In Wnt4+/+
mice, expression of Wnt4 in the thymus
was similar in neonates and adults. How-
ever, the abundance of Wnt4 transcripts
was much greater in the BM of neonates
than adult mice (Figure 7A). Wnt4–/– mice
displayed a normal BM cellularity with
a selective decrease in the frequencies
of Flt3+ and Flt3– LSKs (Figures 7B and
7C). Furthermore, compared with
Wnt4+/+ littermates, Wnt4+/– and Wnt4–/–
mice showed a dose-dependent de-
crease in thymic cellularity (Figure 7B).
Our studies in mice overexpressing
Wnt4 demonstrated that Wnt4 influenced thymopoiesis by regu-
lating the thymic ETP pool size and not by increasing the number
of T cells produced per ETP. In accordance with this notion, thy-
mic hypocellularity in Wnt4–/– mice correlated with decreased
numbers of ETPs without changes in the proportions of thymo-
cyte subsets downstream of ETPs (Figure 7D). BM Flt3+ LSKs
are probably the main precursors of thymic ETPs in normalImmunity 29, 57–67, July 18, 2008 ª2008 Elsevier Inc. 63
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overexpressing Wnt4 (Figure 4). In line with this, we noted that
the ratio of thymic ETPs per BM Flt3+ LSK was reduced in
Wnt4–/– mice (31) relative to controls (11.5) (Figure 7E).
Figure 7. Wnt4-DeficientMice Display Low Frequencies of LSKs and
Thymic Hypocellularity
(A) Levels of Wnt4 transcripts in Wnt4–/–, Wnt4+/–, and Wnt4+/+ (WT) neonates
as well as WT adults were assessed by real-time RT-PCR. Transcript levels
normalized to Gapdh are expressed as mean ± SEM relative to a reference
adult thymus. ‘‘ND’’ stands for nondetectable.
(B) Cell numbers in the thymus and BM (two tibiae and femurs) of Wnt4–/–,
Wnt4+/–, and WT neonates.
(C) Percentages of LSKs, Flt3+ LSKs, and Flt3– LSKs in Linlo/ BM cells from
Wnt4–/– and WT neonates. As an illustration of the gating strategy for identifi-
cation of LSKs in neonatal BM, representative dot plots (gated on Linlo/neg
cells) are shown for Wnt4–/– (top) and Wnt4+/+ (bottom) neonates.
(D) Cell numbers (top graphs) and proportion (bottom graphs) of thymocyte
subsets in Wnt4–/– and WT neonates.
(E) Ratio of thymic ETPs per BM Flt3+ LSK in Wnt4–/– and WT neonates. Data
in all panels represent the mean ± SEM for 4 to 10 mice per group. *p < 0.05,
**p < 0.03, ***p < 0.01, yp < 0.005, and yyp < 0.001.64 Immunity 29, 57–67, July 18, 2008 ª2008 Elsevier Inc.Wnt4 Activates JNK but Does Not Stabilize
b-Catenin in FL Cells
Although targets of the Wnt canonical pathway are cell and con-
text dependent, some classical target genes, such as Ccnd1,
Fos, and Jun, behave in the same fashion in various cell types,
including hematopoietic cells (Staal et al., 2004; Scheller et al.,
2006; Kirstetter et al., 2006). Lack of upregulation of these clas-
sical canonical pathway target genes Ccnd1, Fos, and Jun as
well as Myc in LSKs from mice overexpressing Wnt4 strongly
argued against induction of the canonical pathway by Wnt4
(Figure 6A). To see whether Wnt4 activated noncanonical signal-
ing in hematopoietic progenitor cells, we cocultured FL cells on
Wnt4-producing and control fibroblasts for 15 min to 2 hr.
Because Jun-N-terminal kinase (JNK) can be activated via mul-
tiple branches of noncanonical Wnt signaling (Liang et al., 2003;
Osafune et al., 2006; Park et al., 2006), we used it as a surrogate
marker for the activation of noncanonical pathways. We
detected a strong activation of a 54 kDa isoform of JNK, presum-
ably JNK2, as shown by increased phosphorylation of the activa-
tion-loop residues at early time points in the presence of Wnt4
as compared to control (Figure 6B). In contrast, the amount
of b-catenin did not increase even after 2 hr of coculture
(Figure 6B). These results strongly suggest that, in immature he-
matopoietic cells, Wnt4 acts via a JNK-dependent noncanonical
pathway.
DISCUSSION
We report that overexpression of Wnt4 in hematopoietic cells of
adult mice had two major and related consequences: expansion
of BM Flt3+ LSKs (LMPPs) and enhancement of thymopoiesis.
Besides, overexpression of Wnt4 had other effects of lesser
magnitude: an increase in the frequency of HSCs (Flt3– LSKs),
positive effects on discrete stages of B lymphopoiesis and mye-
lopoiesis, and a negative impact on erythropoiesis. Its primary
effect on Flt3+ LSKs in adult mice makes Wnt4 unique. In partic-
ular, the impact of Wnt4 on hematopoiesis is drastically different
from that of b-catenin. Indeed, activation of b-catenin regulates
two processes: renewal of HSCs and thymocyte development
downstream of DN3 thymocytes (Gounari et al., 2001; Xu et al.,
2003; Kirstetter et al., 2006). In contrast, Wnt4 overexpression
had only a modest impact on HSCs and had no specific effect
on thymocyte subsets downstream of the DN2 development
stage. Thus, Wnt4 overexpression primarily expanded BM
Flt3+ LSKs, ETPs, and DN2 thymocytes, whereas b-catenin reg-
ulates processes upstream of Flt3+ LSKs and downstream of
DN2 thymocytes. For putting into perspective the differential im-
pact of Wnt4 on HSCs and Flt3+ LSKs in adult mice, it is impor-
tant to consider that HSCs but not Flt3+ LSKs have self-renewal
potential. Thus, the 2-fold increase in the number of Flt3– LSKs
observed in recipients of Wnt4+ FL cells could result from as little
as one additional mitosis over a 16 week period. In contrast, be-
cause the half-life of Flt3+ LSKs is a matter of days (less than
a week [Yang et al., 2005]), a conservative estimate would be
that the 3.3-fold expansion of BM Flt3+ LSKs induced by Wnt4
roughly corresponds to doubling of the Flt3+ LSK compartment
size every 96 hr.
How did Wnt4 expand adult Flt3+ LSKs? Wnt4 overexpression
promoted cell-cycle arrest and enhanced the survival of Flt3+
Immunity
Wnt4 Enhances ThymopoiesisLSKs. Accordingly, gene-expression profiling in LSKs revealed
that Wnt4 induced nine genes that promote cell maintenance
and five cell-cycle inhibitors and upregulatedBcl2l1. We surmise
that Wnt4’s effects on cell cycling and survival are mechanisti-
cally linked. Indeed, hematopoietic stem and progenitor cells ac-
cumulate DNA damage that impinges more rapidly and exten-
sively on Flt3+ LSKs than HSCs over time (Rossi et al., 2007).
Depletion of Flt3+ LSKs with relative preservation of Flt3– LSKs
is a hallmark of hematopoietic senescence, explained by the
fact that the proportion of cycling cells is greater in Flt3+ LSKs
than HSCs (Passegue et al., 2005). Cells that cycle more rapidly
are more susceptible to DNA-damage responses (growth arrest
or apoptosis) that are activated in cycling cells at the G1/S and
G2/M checkpoints (Rossi et al., 2007). It therefore makes sense
that by decreasing the proportion of cycling and apoptotic cells,
Wnt4 predominantly affected Flt3+ rather than Flt3– LSKs be-
cause the former cycles more rapidly and undergoes more
apoptosis than the latter.
Our studies in Wnt4–/– mice demonstrated that Wnt4 is neces-
sary to sustain a normal pool size of BM LSKs and a normal thy-
mic cellularity. However, we noted one discrepancy between
conclusions based on our loss-of-function (in neonates) and
gain-of-function (in adult mice) models. In the former case,
lack of Wnt4 affected equally Flt3+ and Flt3– BM LSKs, whereas
in the latter case, Wnt4 affected chiefly Flt3+ LSKs. This disparity
may be due to the differential cell-cycle status of Flt3– LSKs in
neonates versus adult mice. Unlike what is found in adult mice,
the vast majority of Flt3– LSKs are cycling in neonates (Bowie
et al., 2006). That Wnt4 acts mainly by promoting cell-cycle
arrest may therefore explain why its effect on Flt3– BM LSKs is
more dramatic in neonates than in adult mice. Alternatively,
Wnt4 overexpression may have only a modest effect on expan-
sion of the adult HSC pool because other elements of the stem
cell niche in bone marrow are limiting.
The most biologically relevant effect of Wnt4 was on thymo-
poiesis. Thymic cellularity was decreased inWnt4–/– mice and in-
creased when Wnt4 was overexpressed. How did Wnt4 regulate
thymopoiesis? In both models, the key effect of Wnt4 was on the
numbers of thymic ETPs. Deletion or overexpression of Wnt4
modulated the numbers of ETPs and was associated with com-
mensurate variations in the numbers of more mature thymocyte
subsets. Wnt4 did not influence the proportion of thymocyte
subsets downstream of ETPs. Moreover, Wnt4 did not affect in
vitro expansion or differentiation of thymocytes downstream of
ETPs. How did Wnt4 regulate the ETP pool size? In adult mice,
thymic cellularity strongly and specifically correlated with the fre-
quency of BM Flt3+ LSKs. This suggests that the effect of Wnt4 is
at least in part prethymic and contingent upon expansion of BM
Flt3+ LSKs. That conclusion is consistent with the fact that Flt3+
LSKs display better thymus homing efficiency than other pro-
genitor subsets (e.g., HSCs and CLPs) and that Flt3 ligand-defi-
ciency decreases thymic cellularity and the frequency of ETPs,
whereas injection of Flt3 ligand enhances thymopoiesis (Fry
et al., 2004; Sambandam et al., 2005). After entry in the thymus,
Flt3+ LSKs undergo substantial expansion (Kenins et al., 2008).
In line with this, we noted that the ratio of thymic ETPs per BM
Flt3+ LSK was decreased in Wnt4–/– mice relative to wild-type lit-
termates (p < 0.05). Furthermore, expansion of ETPs and DN2
thymocytes (9- to 10-fold) in recipients of Wnt4+ FL cells wasmore dramatic than that of BM Flt3+ LSKs (3.3-fold). This sug-
gests that the role of Wnt4 may not be strictly prethymic and that
Wnt4 may also support the intrathymic expansion of Flt3+ LSKs.
An alternative hypothesis would be that lack of Wnt4 hinders en-
try of Flt3+ LSKs in the thymus. Further studies are required to
determine to what extent the key effects of Wnt4 on Flt3+ LSKs
are prethymic (increased frequency of thymic settlers) and intra-
thymic (increased expansion).
Although there is some evidence that Wnt4 may signal through
the canonical (b-catenin-dependent) Wnt pathway, it has been pri-
marilyassociatedwithnoncanonical signaling.Thus, ectopic Wnt4
expression in Xenopus does not cause the b-catenin-dependent
duplication of anterior-posterior axis but rather results in defective
convergence-extension movements (Du et al., 1995; Veeman
et al., 2003). Moreover, Wnt4 has been demonstrated to regulate
colony formation by renal progenitor cells in a Rac- and JNK-
dependent manner reminiscent of the noncanonical planar cell
polarity pathway (Osafune et al., 2006). In our model, Wnt4 acti-
vated JNK but neither stabilized b-catenin nor induced classic tar-
gets of the canonical pathway. Furthermore, as mentioned above,
the effects of Wnt4 on hematopoiesis and thymopoiesis were
totally different from those of b-catenin. These data provide com-
pelling evidence that the influence of Wnt4 on hematolymphoid
progenitors is mediated by the noncanonical pathway. The notion
that noncanonical Wnt signals may determine the fate of hemato-
poietic stem and progenitor cells reinforces the need to develop
new tools for analysis of noncanonical Wnt signaling.
HSC aging is characterized by downregulation of genes medi-
ating lymphoid specification and upregulation of genes mediat-
ing myeloid specification in a concerted program to skew the lin-
eage potential of HSCs from lymphopoiesis toward myelopoiesis
with age (Rossi et al., 2005a). Accordingly, compared to young
mice, old mice show normal or even increased numbers of Flt3–
LSKs but decreased numbers of BM Flt3+ LSKs and of thymic
ETPs (Linton and Dorshkind, 2004; Zediak et al., 2007). Substan-
tial evidence suggests that changes associated with HSC aging
are responsible, at least in part, for thymic senescence (Zediak
and Bhandoola, 2005; Montecino-Rodriguez and Dorshkind,
2006). The present work demonstrates that Wnt4 expanded
BM Flt3+ LSKs and thymic ETPs, enhanced thymopoiesis, and
activated a noncanonical signaling pathway. Furthermore, we
observed that expression of Wnt4 in the BM was much lower in
adults than neonates. It will therefore be of considerable interest
to determine whether impairment of noncanonical Wnt signaling
may underlie HSC senescence and thymic involution and
whether these processes can be reverted by provision of Wnt4.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (B6) and B6.SJL-PtprcaPep3bBoyJ (Ly5a) (B6.SJL; Ly 5.1+) mice
were purchased from The Jackson laboratory (Bar Harbor, ME). Wnt4-defi-
cient mice have been previously described (Stark et al., 1994). Mice were
bred and housed under specific pathogen-free conditions in sterile ventilated
racks at the Institute for Research in Immunology and Cancer according to the
standards of the Canadian Council on Animal Care.
Flow-Cytometry Analysis and Cell Sorting
The following antibodies were used: PE-Cy7 and Pe-Cy5 anti-CD8a (53-6.7),
APC-Cy7 anti-CD4 (GK1.5), APC anti-TCRb (H57), PE anti-CD44 (IM7), PEImmunity 29, 57–67, July 18, 2008 ª2008 Elsevier Inc. 65
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Wnt4 Enhances Thymopoiesisanti-CD19 (1D3), APC-Cy7 anti-CD25 (PC61.5), PE and biotin anti-CD127 (IL-
7Ra, A7R34), PE-Cy7 and APC anti-CD117 (c-Kit, 2B8), Pe-Cy5.5 anti-Sca-1
(E13-161.7), PE anti-CD135 (Flt3, A2F10.1), Alexa Fluor 647 anti-CD34
(MEC14.7), PE anti-CD16CD32 (2.4G2), APC anti-CD11b (M1/70), APC-Cy7
anti-Ly6G (Gr1), PE anti-CD71 (C2), biotin anti-Ter-119 (Ly-76), PE Texas-
Red anti-B220 (RA3-6B2), PE-Cy5 anti-CD24 (M1/69), PE-Cy7 anti-IgM (R6-
60.2), PE anti-IgD (11-26C.2a), Biotin anti-CD43 (S7), and Alexa Fluor 350 An-
nexin-V. For cell-cycle analysis, Hoechst 33342 was used in accordance with
the manufacturer’s instructions (Invitrogen, Burlington, ON, Canada). Biotin-
labeled antibodies used in the lineage ‘‘cocktail’’ included anti-CD8a (53-
6.7), anti-CD8b (53-5.8), anti-NK1.1 (PK136), anti-TCRb (H57), anti-CD11c
(HL3), anti-TCRgd (GL-3), and mouse lineage panel (CD33, CD11b, CD45R/
B220, Ly6C, Ly6G [Gr-1], and TER-119/erythroid cells [Ly-76]). Biotinylated
antibodies were detected with streptavidin PE-Cy7, PE-Cy5, and APC-Cy7.
Antibodies were purchased from BD PharMingen (San Diego, CA, USA), Invi-
trogen, Cedarlane Laboratories (Hornby, ON, Canada), or Biolegend (San
Diego, CA, USA). Cells were analyzed on an LSRII flow cytometer with DiVa
software and sorted on a three laser FACSAria (BD Biosciences, Mountain
View, CA, USA).
Retroviral Infection and Transplantation of E14.5 Fetal Liver Cells
We subcloned mouse Wnt4 gene (pUSEamp-Wnt4 [Upstate biotechnology,
Lake Placid, NY]) within the multiple cloning site of pMSLV-IRES-GFP retroviral
vector. Production of vesicular stomatitis virus-pseudotyped (VSV) retrovi-
ruses and infection of hematopoietic cells were done as previously described
(Chagraoui et al., 2006). E14.5 FL cells harvested from pregnant C57BL/6 mice
were prestimulated for 24 hr in Dulbecco-modified Eagle medium containing
15% fetal-bovine serum, 6 ng/mL murine interleukin (IL)-3, 100 ng/mL murine
Steel factor, and 10 ng/mL human IL-6. FL cells were then transferred on irra-
diated GP+E-86 cells transduced with pMSLV-IRES-GFP or pMSLV-Wnt4-
IRES-GFP with 6 mg/mL of polybrene for 48 hr. For transplantation, lethally
irradiated 7- to 10-week-old B6.SJL-PtprcaPep3b/BoyJ (Ly5.1) recipient
mice were injected intravenously with 2 3 106 C57BL/6 (Ly5.2) E14.5 FL cells
harvested from coculture with viral producer cells.
Quantitative RT-PCR
Quantitative RT-PCR was performed as previously described with an ABI
PRISM 7900HT Sequence Detection System (Applied Biosystems, Foster
City, CA, USA) (Baron et al., 2007).
Immunoblots
FL cells were resuspended in prestimulation medium and layered on irradiated
GP+E-86-Wnt4-GFP or GP+E-86-GFP control cells. Aliquots were taken after
15 min, 60 min, and 120 min coculture. Cells were pelleted and lysed for 10 min
on ice in cold radio-immunoprecipitation buffer (50 mM Tris-HCl [pH 7.4], 1%
Noniodet P-40, 0.25% sodium deoxycholate, and 150 mM NaCl) supple-
mented with complete protease inhibitor cocktail (Roche Molecular Biochem-
icals, Laval, QC, Canada) and phosphatase inhibitors (1 mM Na3VO4 and 5 mM
NaF). The lysates were cleared by centrifugation, and the protein content was
measured by the Bradford method (Biorad, Mississauga, ON, Canada). Sam-
ples were resolved by SDS-PAGE and immunoblotted with the following anti-
bodies: anti-b-actin (AC-15) from Sigma-Aldrich (St. Louis, MO, USA), anti-
b-catenin (clone 14) from BD PharMingen (San Diego, CA, USA), anti-JNK
(56G8), and anti-phospho-JNK (T183/Y185) from Cell Signaling Technology
(Beverly, MA, USA). Quantification of band intensities was done using Image
J Software.
Statistical Analysis
The means of normally distributed data were compared with the Student’s t
test, with a p value of < 0.05 considered to be significant.
SUPPLEMENTAL DATA
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with this article online at http://www.immunity.com/cgi/content/full/29/1/57/
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